Cervical lymphadenectomy is beneficial for patients with carcinoma of the upper and mid-thoracic esophagus

Diseases of the Esophagus

Volumn 16, Issue 1, 2003, Pages 4-8

  Nakagawa, Satoru ^a   Nishimaki, T ^a   Kosugi, S ^a   Ohashi, M ^a   Kanada, T ^a   Hatakeyama, K ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROPYRIMIDINE DERIVATIVE; FLUOROURACIL; VINDESINE;

ADULT; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; BLEEDING; BRAIN INFARCTION; BRAIN INJURY; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CAUSE OF DEATH; CERVICAL LYMPH NODE; CHYLOTHORAX; ENTEROCOLITIS; ESOPHAGUS CANCER; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HEART DISEASE; HUMAN; KIDNEY FAILURE; LIVER FAILURE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PLEURA EMPYEMA; PNEUMONIA; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SURVIVAL RATE; VOCAL CORD PARALYSIS;

ADULT; AGED; BIOPSY, NEEDLE; CASE-CONTROL STUDIES; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; MALE; MIDDLE AGED; NECK; NEOPLASM STAGING; PROBABILITY; RADIOTHERAPY, ADJUVANT; REFERENCE VALUES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0037616040     PISSN: 11208694     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2050.2003.00286.x     Document Type: Article

References (14)

1. Orringer M B. Editorial comment on 'occult cervical nodal metastasis in esophageal cancer: Preliminary results of three-field lymphadenectomy.' J Thorac Cardiovasc Surg 1997; 113: 538-539.
2. Altorki N, Skinner D. Occult cervical node metastasis on esophageal cancer: Preliminary results of three-field lymphadenectomy. J Thorac Cardiovasc Surg 1997; 113: 540-544.
3. Kato H, Tachimori Y, Watanabe H et al. Lymph node metastasis in thoracic esophageal carcinoma. J Surg Oncol 1991; 48: 106-111.
4. Akiyama H, Tsurumaru M, Udagawa H, Kajiyama Y. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 1994; 220: 364-372.
5. Baba M, Aikou T, Yoshinaka H et al. Long-term results of subtotal esophagectomy with three-field lymphadenectomy for carcinoma of the thoracic esophagus. Ann Surg 1994; 219: 31-36.
6. Fujita H, Kakegawa T, Yamana H et al. Mortality and morbidity rates, postoperative course, quality of life, and prognosis after extended radical lymphadenectomy for esophageal cancer. Ann Surg 1995; 222: 654-662.
7. Nishimaki T, Tanaka O, Suzuki T, Aizawa K, Hatakeyama K, Muto T. Patterns of lymphatic spread in thoracic esophageal cancer. Cancer 1994; 74: 4-11.
8. Sobin L H, Wittekind C H. TNM Classification of Malignant Tumors, 5th edn. New York: Wiley-Liss, 1997.
9. Nishimaki T, Suzuki T, Suzuki S, Kuwabara S, Hatakeyama K. Outcomes of extended radical esophagectomy for thoracic esophageal cancer. J Am Coll Surg 1998; 186: 306-312.
10. Nishimaki T, Suzuki T, Tanaka Y, Aizawa K, Hatakeyama K, Muto T. Intramural metastases from thoracic esophageal cancer: Local indicators of advanced disease. World J Surg 1996; 20: 32-37.
11. Altorki N, Skinner D. Should en bloc esophagectomy be the standard of care for esophageal carcinoma? Ann Surg 2001; 234: 581-587.
12. Matsubara T, Ueda M, Nagao N, Takahashi T, Nakajima T, Nishi M. Cervicothoracic approach for total mesoesophageal dissection in cancer of the thoracic esophagus. J Am Coll Surg 1998; 187: 238-245.
13. Igaki H, Kato H, Tachimori Y, Nakanishi Y. Cervical lymph node metastasis in patients with submucosal carcinoma of the thoracic esophagus. J Surg Oncol 2000; 75: 37-41.
14. Orringer M B, Marshall B, Iannettoni M D. Transhiatal esophagectomy: Clinical experience and refinements. Ann Surg 1999; 230: 392-403.